期刊文献+

程序性细胞死亡4在结直肠癌中的作用 被引量:4

Role of programmed cell death 4 in colorectal cancer
下载PDF
导出
摘要 程序性细胞死亡4(programmed cell death 4,PDCD4)基因定位于染色体10q24,通过阻碍真核生物翻译起始因子复合物eIF4F合成,在转录和翻译水平抑制肿瘤发展。PDCD4基因在结直肠癌中的表达调节机制非常复杂,涉及多条信号转导通路,并影响肿瘤细胞增殖、侵袭、转移及耐药。该文综述了PDCD4在结直肠癌发展中分子机制、表达及预后判断等相关研究进展。 The programmed cell death 4(PDCD4) gene is located on chromosome 10q24 and inhibits tumor progression at transcriptional and translational levels by blocking the eukaryotic biological translation initiation factor complex eIF4F synthesis. The regulatory mechanism of PDCD4 gene expression in colorectal cancer(CRC) is sophisticated, by which involves multiple signal transduction pathways and affects the proliferation, invasion, metastasis and drug resistance of CRC cells. That review summarizes the molecular mechanisms, expression and prognosis of PDCD4 in the development of CRC.
作者 龙嘉莉 殷玉婷 朱伟 LONG Jia-li;YIN Yu-ting;ZHU Wei(Department of Pathology, Guangdong Medical University, Dongguan 523808, Chin)
出处 《广东医科大学学报》 2017年第6期588-591,共4页 Journal of Guangdong Medical University
基金 国家自然科学基金(No.81472275) 广东省自然科学基金(No.2014A030313542)
关键词 PDCD4 结直肠癌 综述文献 PDCD4 colorectal cancer review
  • 相关文献

参考文献2

二级参考文献17

  • 1黄彦钦,袁瑛,王亚平,朱明,张苏展,郑树.中国人遗传性非息肉病性结直肠癌错配修复基因大片段缺失研究[J].中华医学遗传学杂志,2005,22(1):88-90. 被引量:5
  • 2邓艳红,兰平.综合治疗对中低位直肠癌功能保护的意义[J].中华胃肠外科杂志,2007,10(4):396-398. 被引量:4
  • 3Chau I, Cunningham D. Chemotherapy in colorectal cancer: new options and new challenges[J]. Br Med Bullet, 2002, 64: 159- 180.
  • 4Pratt S, Shepard RL, Kandasamy RA, et al. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites [J]. Mol Cancer Ther, 2005, 4(5): 855-863.
  • 5Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci U S A, 2006, 103(7) ..2257-2261.
  • 6Bandr6s E, Cubedo E, Agirre X, et al. Identification by real- time PCR of 13 mature microRNAs differentially expressed in coloreetal cancer and non-tumoral tissue[J]. Mol Cancer, 2006, 5:29.
  • 7Li S, Liang Z, Xu L, et al. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases [J]. Mol Cell Biochem, 2012, 360(1-2) =147-158.
  • 8Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4) :425-436.
  • 9Wang P, Zou F, Zhang X, et al. microRNA-21 negativelyregulates Cdc25A and cell cycle progression in colon cancer cells [J]. Cancer Res, 2009, 69(20):8157-8165.
  • 10Pan X, Wang ZX, Wang R. MicroRNA-21: A novel therapeutic target in human cancer[J]. Cancer Biol Ther, 2010, 10(12): 1224-1232.

共引文献22

同被引文献4

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部